News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

Belfast-based techbio company AMPLY Discovery Limited has raised over £1.4m in grant funding to develop new drug products using its proprietary AI-driven drug discovery platform.

Medicines Discovery Catapult (MDC) and ZEISS have joined forces to improve drug discovery and early development of complex medicines by harnessing the power of advanced microscopy solutions.

Biorelate, a UK-based AI start up, is offering all researchers free use of Galactic, its cloud-based web tool, to support biomedical research while lab access is restricted around the world.

Shortened development time for developing a rapid Point of Care COVID-19 test

This RSSL complimentary webinar series, hosted by Dr Tim Sandle, will guide you through the complexities around sterile products manufacturing, control, testing and release.

Limited number of computational chemistry consultancy sessions for start-ups and small to medium sized enterprises (SMEs) and academics working on drug discovery projects.

Manchester Molecular Pathology Innovation Centre (MMPathIC) has developed a virtual pipeline model for the development of novel biomarkers and technologies; offering a simplified and streaml...

The non-accredited, Leadership Accelerator Programme is aimed at individuals who are currently in a position or aspire to be in a position that requires them to lead and manage people, proje...

Newcastle-based clinical research software house, Datatrial is predicting it will double turnover and increase its headcount by 50 per cent by the end of 2020, after being successful in two ...

Sign up to our Newsletter

Subscribe

* indicates required

Our Valued Sponsors & Partners